+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk



Ductal involvement by cells of atypical lobular hyperplasia in the breast: a long-term follow-up study of cancer risk



Human Pathology 19(2): 201-207



A cohort study of women with ductal involvement by cells of atypical lobular hyperplasia (DIALH) revealed an incidence of 1.4% in benign biopsy specimens. When combined with diagnostic lobular unit alterations of atypical lobular hyperplasia (ALH), a consequent risk of invasive carcinoma of 6.8 times that in the general population was found. This relative risk for women with ALH and DIALH approaches the risk for lobular carcinoma in situ, whereas the risk for ALH with or without DIALH is 4.3 and the risk for ALH without DIALH is reduced to 2.7. Only definitive changes of DIALH with an insinuated characteristic population of cells between attenuated luminal cells and basement membrane should be so diagnosed. DIALH in association with lobular alterations that are borderline with regard to a diagnosis of lobular carcinoma in situ will increase the certainty that a medically meaningful increased risk for subsequent invasive cancer is indicated.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039877922

Download citation: RISBibTeXText

PMID: 3343034

DOI: 10.1016/s0046-8177(88)80350-2


Related references

Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology 48(1): 25-29, 2016

Both atypical lobular hyperplasia alh and atypical ductal hyperplasia adh predict for bilateral breast cancer risk. Laboratory Investigation 66(1): 13A, 1992

Differences in Breast Cancer Risk Between Atypical Lobular Hyperplasia and Atypical Ductal Hyperplasia. Advances in Anatomic Pathology 15(2): 119-120, 2008

Ductal cells, hyperplasia and breast cancer risk Results from a long-term follow-up study of lavage patients. Breast Cancer Research & Treatment 76(Suppl. 1): S40, 2002

Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Annals of Surgical Oncology 19(10): 3131-3138, 2012

Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia. Annals of Surgical Oncology 18(2): 463-467, 2011

Mammary ductal involvement by cells of atypical lobular hyperplasia. Laboratory Investigation 54(1): 48A, 1986

Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision With Long-Term Follow-up. Archives of Pathology and Laboratory Medicine 142(3): 391-395, 2018

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Annals of Surgical Oncology 22(10): 3346-3349, 2015

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Breast Diseases: A Year Book Quarterly 27(1): 81-82, 2016

Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiology, Biomarkers & Prevention 22(9): 1529-1537, 2014

Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Diagnostic Pathology 9: 121, 2014

Atypical ductal and lobular hyperplasia of the breast. Gynecologie Obstetrique and Fertilite 37(10): 814-819, 2009

Lobular carcinoma in situ and atypical lobular hyperplasia of the breast: follow-up in New South Wales. Pathology 10(2): 195-196, 1978

A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Zhonghua Wai Ke Za Zhi 45(13): 874-876, 2007